Cerus (CERS) Total Liabilities (2010 - 2026)
Cerus (CERS) reported Total Liabilities of $154.6 million for Q1 2026, up 2.72% on a YoY basis from $150.5 million in Q1 2025, and down 1.45% sequentially from $156.9 million in Q4 2025.
Cerus (CERS) Total Liabilities (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Total Liabilities data on file, last reported at $154.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 2.72% year-over-year to $154.6 million; the trailing twelve-month figure through Mar 2026 stood at $154.6 million (up 2.72% YoY), and the FY2025 full-year result was $156.9 million, up 8.94% from the prior year.
- Total Liabilities retreated to $154.6 million in Q1 2026, from $156.9 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $156.9 million in Q2 2025 to a low of $135.2 million in Q2 2024.
- A 5-year average of $146.8 million and a median of $147.2 million in 2023 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities fell 13.75% in 2024 and rose 16.06% in 2025, its largest moves.
- Tracing CERS's Total Liabilities over 5 years: stood at $149.5 million in 2022, then fell by 3.49% to $144.3 million in 2023, then dropped by 0.2% to $144.0 million in 2024, then rose by 8.94% to $156.9 million in 2025, then dropped by 1.45% to $154.6 million in 2026.
- Business Quant data shows CERS's Total Liabilities at $154.6 million in Q1 2026, $156.9 million in Q4 2025, and $153.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.45 Bn | 175.15 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 108.03 Bn | 98.81 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 68.19 Bn | 66.74 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Dexcom | 28.24 Bn | 27.13 Bn | 750.30 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 27.99 Bn | 25.70 Bn | 1.98 Bn | 26.23 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | 5.17 Bn |
| 9 | Koninklijke Philips | 23.72 Bn | 20.60 Bn | 2.07 Bn | 18.55 Bn |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn | 154.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 154.62 Mn |
| Dec 31, 2025 | 156.89 Mn |
| Sep 30, 2025 | 152.98 Mn |
| Jun 30, 2025 | 156.90 Mn |
| Mar 31, 2025 | 150.53 Mn |
| Dec 31, 2024 | 144.02 Mn |
| Sep 30, 2024 | 135.26 Mn |
| Jun 30, 2024 | 135.20 Mn |
| Mar 31, 2024 | 138.97 Mn |
| Dec 31, 2023 | 144.30 Mn |
| Sep 30, 2023 | 156.82 Mn |
| Jun 30, 2023 | 147.17 Mn |
| Mar 31, 2023 | 149.77 Mn |
| Dec 31, 2022 | 149.53 Mn |
| Sep 30, 2022 | 141.33 Mn |
| Jun 30, 2022 | 139.70 Mn |
| Mar 31, 2022 | 141.50 Mn |
| Dec 31, 2021 | 151.88 Mn |
| Sep 30, 2021 | 137.87 Mn |
| Jun 30, 2021 | 138.99 Mn |